Finance Watch: Adlai Nortye Raises $97.5m In IPO, Brings US Total To 18
Madrigal’s FOPO Grosses $500m After NASH Drug Filing
Public Company Edition: Cancer-focused Adlai Nortye launched a concurrent initial public offering and private placement, while four other drug developers announced or completed SPAC mergers. Also, Sobi grossed $540m in a rights issue and Immunovant followed early data with a $450m FOPO.
